BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19659473)

  • 61. Negative predictive value of TST and IGRA in anti-TNF treated patients.
    Campainha S; Gomes T; Carvalho A; Duarte R
    Eur Respir J; 2012 Sep; 40(3):790-1. PubMed ID: 22941549
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [False-positive interferon-gamma test?].
    Priwitzer M; Unger C; Spieth F; Klittich G
    Pneumologie; 2007 Mar; 61(3):157-8. PubMed ID: 17342575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON-TB Gold and tuberculin skin tests.
    Prignano F; Bartoloni A; Bartalesi F; Gori A; Ricceri F; Cavallo A; Attala L; Mantella A
    Int J Dermatol; 2014 Aug; 53(8):e372-4. PubMed ID: 24898978
    [No Abstract]   [Full Text] [Related]  

  • 65. Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases.
    Kleinert S; Kurzai O; Elias J; Marten K; Engelke C; Feuchtenberger M; Sandstede J; Frosch M; Tony HP; Kneitz C
    Ann Rheum Dis; 2010 Apr; 69(4):782-4. PubMed ID: 20185504
    [No Abstract]   [Full Text] [Related]  

  • 66. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
    Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of tuberculin skin test and interferon-gamma assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-alpha therapy.
    Balato N; Ayala F; Gaudiello F; Monfrecola G; Cimmino G; Ponticiello A; Bocchino M; Matarese A; Sanduzzi A
    Br J Dermatol; 2008 Apr; 158(4):847-9. PubMed ID: 18241281
    [No Abstract]   [Full Text] [Related]  

  • 68. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.
    Lee EH; Kang YA; Leem AY; Park MS; Kim YS; Kim SK; Chang J; Kim SY
    Sci Rep; 2017 Jul; 7(1):6473. PubMed ID: 28743918
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
    Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
    Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.
    Sanduzzi A; Bocchino M; Atteno M; Costa L; Ponticiello A; Matarese A; Spanò A; Bruner V; Peluso R; Aquino MM; Del Puente A; Scarpa R
    J Rheumatol Suppl; 2012 Jul; 89():82-5. PubMed ID: 22751601
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis.
    Huo R; Romanelli P
    Am J Clin Dermatol; 2010; 11 Suppl 1():39-40. PubMed ID: 20586506
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Double screening for latent tuberculosis infection in patients treated with anti-tumor necrosis factor α.
    Sempau L; González-Sixto B; Sánchez-Sambucetty P; de Morales JM; Pérez-Bustillo A; Rodríguez-Prieto MA
    Arch Dermatol; 2011 Oct; 147(10):1233-4. PubMed ID: 22006153
    [No Abstract]   [Full Text] [Related]  

  • 74. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
    Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
    Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Latent tuberculosis infection and interferon-gamma release assays: what new knowledge did we gain through the Journal in 2009?
    van der Werf MJ; van Leth F
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1525-9. PubMed ID: 21144236
    [No Abstract]   [Full Text] [Related]  

  • 76. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.
    Harstad I; Winje BA; Heldal E; Oftung F; Jacobsen GW
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1209-11. PubMed ID: 20819271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy.
    Lighter-Fisher J; Surette AM
    Obstet Gynecol; 2012 Jun; 119(6):1088-95. PubMed ID: 22569120
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.
    Bellete B; Coberly J; Barnes GL; Ko C; Chaisson RE; Comstock GW; Bishai WR
    Clin Infect Dis; 2002 Jun; 34(11):1449-56. PubMed ID: 12015690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.